We are monitoring the impact of COVID-19 on Wearable Cardioverter Defibrillator Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4407
Share on
Share on

Global Wearable Cardioverter Defibrillator Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Conditions, End User and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4407
Pages: 178

Wearable Cardioverter Defibrillator Market Size (2021 to 2026)

The global market size for Wearable Cardioverter Defibrillators is expected to register a healthy growth rate during the forecast period.

Wearable cardioverter defibrillators (WCDs) are small, portable devices that deliver an electrical shock to the heart to avoid sudden cardiac death (SDC). External (automated external) and internal (implantable) defibrillators are the two types of defibrillators.  In the wearable cardioverter defibrillator, an external defibrillator is connected to a jacket worn by the patient. It is frequently used in patients to bridge the gap between the need for an implantable cardioverter-defibrillator and the availability of one. A wearable cardioverter defibrillator gives their doctor more time to analyze their long-term arrhythmic risk and take necessary measures to avoid a fatal cardiac arrest.

MARKET DRIVERS:

The global wearable cardioverter defibrillator market is estimated to witness substantial growth during the forecast period. The increase in the prevalence of cardiovascular diseases due to behavioral factors such as tobacco, alcohol, unhealthy diet, obesity, etc., is majorly driving the global wearable cardioverter defibrillator market during the forecast period. The World Health Organization (WHO) has stated that cardiovascular diseases are the primary cause of death, and more than 31% of people worldwide die from this disease. In addition, the increasing awareness of having solid cardiac health among people and the increasing number of sudden cardiac arrest (SCA) incidence boost the global wearable cardioverter defibrillator market during the forecast period.

Moreover, old age people are prompt to get chronic diseases such as heart attacks, where there is an increasing prevalence for better-quality treatment procedures propelling the market's demand. In addition, the rapid growth in the geriatric population all over the world is fueling the wearable cardioverter defibrillator market. For instance, World Health Organisation (WHO) had stated, by 2030, that there might be a tremendous rise of more than 55% of people over 60 years old from 901 million to 1.4 billion. 

The increasing number of capital investments from the private sector and public sector had expected to raise the investments in Research and Development will be a significant opportunity for the market growth. Apart from that increase in technological advancements to improve the signal reception, reduce electrode noise, and reduce the devices' weight and size to increase comfort, the patients are expected to boost the market during the forecast period. Moreover, the people's growing per capita income is predicted to grow the global wearable cardioverter defibrillator market in the upcoming years.

MARKET RESTRAINTS:

The lack of provision to monitor atrial arrhythmias signals significantly restrains the growth of the wearable cardioverter defibrillator market during the forecast period. Moreover, the lack of awareness about sudden cardiac arrests among people is hindering market growth. However, the problems related to the usage of wearable cardioverter defibrillator devices further limit the market's growth. These are the factors restraining the growth of the global wearable cardioverter defibrillator market during the forecast period.

The lack of awareness about wearable cardiovascular defibrillator devices in emerging nations like India, China, etc., is challenging the market's growth. Moreover, the lack of properly skilled professionals and stringent government regulations are expected to limit the market growth during the forecast period.

COVID-19 Impact on Wearable Cardioverter Defibrillator Market:

The COVID 19 had adversely impacted the global economy and global health care sector in 2020. Due to the virus's fast spread during human interactions, almost all countries had implemented lockdown and shut their international borders. The Wearable Cardioverter Defibrillator Market was adversely affected due to the pandemic. With the restriction during the lockdown, the industries had run out of raw materials leading to a decrease in production. Moreover, the disruption of the supply chain globally hampered the market's growth. But the market is rising post-COVID as there is an increasing number of sales from the last months of 2020.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Conditions, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global wearable cardioverter defibrillator market has been segmented and sub-segmented based on the conditions, end-user, and region.

Wearable Cardioverter Defibrillator Market – By Conditions:

  • Peripartum Cardiomyopathy
  • Congenital Heart Disease
  • Inherited Arrhythmias

Based on the condition, the peripartum cardiomyopathy segment is expected to lead with the highest shares of the market during the forecast period. Rising incidences of cardiac arrest problems associated with lifestyle changes are leveling up the demand of this segment. 

Wearable Cardioverter Defibrillator Market – By End User:

  • Hospitals
  • Home Care Settings
  • Cardiology Clinics

Based on the end-user, the homecare settings had registered the highest market share in 2019. The people mostly prefer home treatment and spending on resources to get better treatment or care at home, driving the home care settings segment during the forecast period. Moreover, it became easy for the physicians to assist the patients virtually due to the increase in medical technology advancements, which led to the adoption of home care settings. On the other hand, the Hospital segment has estimated a significant market share during the forecast period owing to the increasing number of hospitals in emerging countries.

Wearable Cardioverter Defibrillator Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America commands the largest market share of the overall industry. It is likely to keep ruling the business sector due to the growing incidence of diseases, enhancement in the healthcare industry, and extended growth. U.S. and Canada contribute the highest to the overall market in the region because of the awareness regarding sudden cardiac arrest and defibrillators. Europe is the second-largest market.

The Market is majorly driven by the rise in demand from developing economies in the Asia Pacific and the Middle East regions. More workstations and business environments are introducing advancements in defibrillators. Therefore, it is projected to benefit the defibrillators market in the aforementioned forecast period.

KEY MARKET PARTICIPANTS:

Some of the notable companies dominating the global wearable cardioverter defibrillator market profiled in this report are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan).

KEY MARKET HAPPENINGS:

  • In 2019, Cardiac Science Corporation, a company that develops, manufactures, and markets diagnostic and therapeutic cardiology products, that also offers automated external defibrillators, diagnostic workstations, and systems, has announced that it was going to be acquired by ZOLL® Medical Corporation, a leading manufacturer of medical devices and related software solutions.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Conditions                  

                                5.1.1 Introduction           

                                5.1.2 Peripartum Cardiomyopathy           

                                5.1.3 Congenital Heart Disease  

                                5.1.4 Inherited Arrhythmias       

                                5.1.5  Y-o-Y Growth Analysis, By Conditions         

                                5.1.6  Market Attractiveness Analysis, By Conditions       

                                5.1.7  Market Share Analysis, By Conditions        

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Home Care Settings            

                                5.2.4 Cardiology Clinics  

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Conditions

                                                6.1.3.3 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Conditions

                                                6.1.4.3 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Conditions

                                                6.1.5.3 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 ZOLL Medical Corporation                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Medtronic PLC (Ireland)                        

                8.3 St. Jude Medical                       

                8.4 Boston Scientific Corporation (U.S.)                 

                8.5 BIOTRONIK SE & Co. KG (Germany)                 

                8.6 LivaNova PLC (U.K.)                

                8.7 Koninklijke Philips N.V. (Netherlands)                            

                8.8 Cardiac Science Corporation (U.S.)                   

                8.9 Physio-Control                          

                8.10 Nihon Kohden Corporation (Japan)                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Conditions and by End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Wearable Cardioverter Defibrillator Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  3. Global Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  7. Global Hospital Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  11. North America Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  15. North America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  18. United States Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  19. United States Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  20. Canada Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  21. Canada Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  22. Europe Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  23. Europe Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  24. Europe Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  25. Europe Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  26. Europe Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  27. Europe Hospital Market, By Region, From 2021 to 2026 (USD Million)
  28. Europe Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  29. Europe Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  30. U.K. Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  31. U.K. Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  32. Germany Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  33. Germany Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  34. France Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  35. France Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  36. Italy Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  37. Italy Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  38. Spain Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  39. Spain Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  40. Asia Pacific Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  41. Asia Pacific Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  42. Asia Pacific Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  43. Asia Pacific Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  44. Asia Pacific Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  45. Asia Pacific Hospital Market, By Region, From 2021 to 2026 (USD Million)
  46. Asia Pacific Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  47. Asia Pacific Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  48. Japan Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  49. Japan Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  50. China Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  51. China Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  52. India Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  53. India Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  54. Australia Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  55. Australia Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  56. South Korea Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  57. South Korea Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  58. Latin America Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  59. Latin America Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  60. Latin America Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  61. Latin America Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  62. Latin America Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  63. Latin America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  64. Latin America Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  65. Latin America Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  66. Brazil Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  67. Brazil Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  68. Argentina Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  69. Argentina Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  70. Mexico Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  71. Mexico Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  72. Rest of Latin America Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  73. Rest of Latin America Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  74. Middle East and Africa Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  75. Middle East and Africa Peripartum Cardiomyopathy Market, By Region, From 2021 to 2026 (USD Million)
  76. Middle East and Africa Congenital Heart Disease Market, By Region, From 2021 to 2026 (USD Million)
  77. Middle East and Africa Inherited Arrhythmias Market, By Region, From 2021 to 2026 (USD Million)
  78. Middle East and Africa Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  79. Middle East and Africa Hospital Market, By Region, From 2021 to 2026 (USD Million)
  80. Middle East and Africa Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  81. Middle East and Africa Cardiology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  82. Middle East Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  83. Middle East Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)
  84. Africa Wearable Cardioverter Defibrillator Market, By Conditions, From 2021 to 2026 (USD Million)
  85. Africa Wearable Cardioverter Defibrillator Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample